Drugs / Measles, Mumps, and Rubella Virus Vaccine Live
Measles, Mumps, and Rubella Virus Vaccine Live
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00109278 | Oct 2004 → May 2005 | measles | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2023-03-06 | Merck Sharp & Dohme LLC | Regulatory US FDA Approves Intramuscular Administration for Merck’s MMRV Family of Vaccines: M-M-RII (Measles, Mumps, and Rubella Virus Vaccine Live), VARIVAX (Varicella Virus Vaccine Live), and ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) merck.com ↗
In the U.S., the only measles, mumps, rubella, and varicella vaccines that can be administered IM are M-M-R ® II , VARIVAX ® , and ProQuad ® . |
All press releases naming this drug 1 release
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps, and Rubella Virus Vaccine Live | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00109278 ↗ |
| Modality | Vaccine | “Comparator: Measles, Mumps, and Rubella Virus Vaccine Live” NCT00109278 ↗ |